Abstracts

Travel Awards


 

HTRS Travel Awards

Please stay tuned: HTRS remains fully committed to distinguishing top abstracts with awards in 2021; however, adjustments may be made to the awards themselves, contingent on travel restrictions due to the ongoing public health concerns.

HTRS Travel Awards reimburse awardees for the cost of airfare, ground transportation, lodging for two nights, and meals on travel days, to attend the meeting, up to a not-to-exceed total of $1,500.00 USD. Travel Award recipients also receive waived meeting registration; only one award per person is allowed.

HTRS will offer awards to investigators who meet the following criteria:

  • At least 14 awards will be given to first authors of the highest-scoring abstracts submitted by trainees or early career investigators working at non-commercial institutions (please refer to the definition of “trainees” and “early career investigators” below)

  • Up to two awards will be given to first authors of an abstract submitted by allied health professionals at any stage in their careers, working at a non-commercial institution

  • Up to one award will be given to the first author of an abstract submitted by an undergraduate student at any stage in his/her career, working  at a non-commercial institution

  • Up to one award will be given to the first author of an abstract submitted by an investigator at any stage of his/her career from North or Central America, working at a non-commercial institution

HTRS defines “trainees” as:

  • Medical Fellows:  MDs/MBBSs or DOs enrolled in accredited fellowship training programs. Fellows must be:

  • In training for a career in hemostasis and/or thrombosis

OR

  • In training for a career that will have a substantial component of, or overlap with, the disciplines of hemostasis and/or thrombosis (such as ob/gyn or cardiology)

  • Postdoctoral Fellows: PhDs pursuing academic research in benign hematology

  • Medical Residents: MDs/MBBSs or DOs pursuing a fellowship in benign hematology

  • Medical students interested in benign hematology

  • Graduate students interested in pursuing research in benign hematology

  • Undergraduate students interested in pursuing research in benign hematology

HTRS defines “early-career investigators” as:

  • Junior attending and junior faculty (MDs/MBBSs, DOs, PhDs) working in non-commercial institutions who are:

    • Within five years of completing training for a career in hemostasis and/or thrombosis at the time of the abstract submission deadline

OR

  • Within five years of completing training for a career that will have a substantial component of, or overlap with, the disciplines of hemostasis and/or thrombosis (such as ob/gyn or cardiology) at the time of the abstract submission deadline

HTRS defines “allied health professionals” as any of the following who are interested in pursuing research in benign hematology:

  • Nurses/Nurse Practitioners

  • Physician Assistants

  • Pharmacists

  • Physical Therapists

  • Medical Technologists or Other Laboratory Professionals

  • Genetic Counselors

  • Social Workers